Ads
related to: first generation versus second antipsychotics for dementia treatment
Search results
Results from the WOW.Com Content Network
The difference between first- and second-generation antipsychotics is a subject of debate. The second-generation antipsychotics are generally distinguishable by the presence of 5HT2A receptor antagonism and a corresponding lower propensity for extrapyramidal side effects compared to first-generation antipsychotics. [15]
The atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), [1] [2] are a group of antipsychotic drugs (antipsychotic drugs in general are also known as tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) largely introduced after the 1970s and used to treat psychiatric ...
Several studies have recently been conducted comparing the number of people affected of tardive dyskinesia with second generation, or more modern, antipsychotic drugs to that of first generation drugs. The newer antipsychotics appear to have a substantially reduced potential for causing tardive dyskinesia. However, some studies express concern ...
Typical antipsychotics (also known as major tranquilizers, and first generation antipsychotics) are a class of antipsychotic drugs first developed in the 1950s and used to treat psychosis (in particular, schizophrenia). Typical antipsychotics may also be used for the treatment of acute mania, agitation, and other conditions.
As of 2011, among those in psychiatric hospitals on antipsychotics about 15 per 100,000 are affected per year (0.015%). [1] In the second half of the 20th century rates were over 100 times higher at about 2% (2,000 per 100,000). [1] Males appear to be more often affected than females. [1] The condition was first described in 1956. [1]
Approximately one out of four individuals treated with first-generation antipsychotics have akathisia. [5] Prevalence rates may be lower for modern treatment as second-generation antipsychotics carry a lower risk of akathisia. [31] In 2015, a French study found an overall prevalence rate of 18.5% in a sample of outpatients with schizophrenia. [33]
Brexpiprazole, sold under the brand name Rexulti among others, is an atypical antipsychotic medication used for the treatment of major depressive disorder, schizophrenia, and agitation associated with dementia due to Alzheimer's disease. [11] [13] [14] The most common side effects include akathisia (a constant urge to move) and weight gain. [12]
In older people with psychosis as a result of dementia, it may increase the risk of death. [6] It is unclear if it is safe for use in pregnancy. [6] Chlorpromazine was developed in 1950 and was the first antipsychotic on the market. [7] [8] It is on the World Health Organization's List of Essential Medicines.
Ads
related to: first generation versus second antipsychotics for dementia treatment